SCIOVANTA

Dissolution · Release kinetics

Dissolution kinetic models: equations, interpretation and how to choose

Zero-order, first-order, Higuchi, Korsmeyer–Peppas, Weibull and Hixson–Crowell are the six models most often fitted to drug-release data. This guide gives each equation in the form used on the original percentage scale, what its parameters mean, and how to compare fits without over-reading R².

Fit all six models to your data Read the fitting conventions

The six models

Q is the cumulative percentage released at time t; k is the model's rate constant.

ModelEquationTypical use
Zero-orderQ = k0 · tConstant-rate release, e.g. some osmotic or reservoir systems
First-orderQ = 100 · (1 − e^(−k1·t))Release proportional to the amount remaining; many immediate-release and porous matrices
HiguchiQ = kH · √tDiffusion from an insoluble matrix (Higuchi, 1963)
Korsmeyer–PeppasQ = kKP · t^nDistinguishing release mechanisms from the exponent n; fitted to the early part of the curve (typically Q ≤ 60 %)
WeibullQ = 100 · (1 − exp(−(t/td)^β))Flexible empirical description of the whole curve (Langenbucher, 1972)
Hixson–Crowell1 − (1 − Q/100)^(1/3) = kHC · tRelease limited by a shrinking particle surface (cube-root law)

Interpreting the Korsmeyer–Peppas exponent n

For non-swelling systems, Ritger and Peppas (1987) gave geometry-dependent limits:

GeometryFickian diffusionAnomalous (non-Fickian)Case II transport
Thin film (slab)n = 0.500.50 < n < 1.00n = 1.00
Cylindern = 0.450.45 < n < 0.89n = 0.89
Spheren = 0.430.43 < n < 0.85n = 0.85

The exponent is only meaningful within the fitted window and for the geometry assumed; it is evidence about mechanism, not proof of it.

Comparing fits: why R² is not enough

A practical workflow

  1. Fit the mean profile and, separately, each replicate — the mean of replicate parameters is not the same as the parameters of the mean curve.
  2. Rank models by adjusted R² and AIC on the same observations; check residual plots.
  3. Fit Korsmeyer–Peppas to Q ≤ 60 % and interpret n against the dosage-form geometry.
  4. Report the equation, fitting window, weighting (SCIOVANTA fits unweighted on the original scale), parameters with units, and the criteria used to choose.

Model fitting describes the data; it does not by itself establish a release mechanism, clinical performance or regulatory acceptability.

Worked numbers on this page are reproduced exactly by the SCIOVANTA calculators linked above. Acceptance criteria differ between regulators and products; check the current guidance that applies to your submission.

References

  1. Costa P, Sousa Lobo JM (2001). Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences 13(2):123–133.
  2. Higuchi T (1963). Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences 52:1145–1149.
  3. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA (1983). Mechanisms of solute release from porous hydrophilic polymers. International Journal of Pharmaceutics 15:25–35.
  4. Ritger PL, Peppas NA (1987). A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. Journal of Controlled Release 5:23–36.
  5. Langenbucher F (1972). Linearization of dissolution rate curves by the Weibull distribution. Journal of Pharmacy and Pharmacology 24:979–981.
  6. Hixson AW, Crowell JH (1931). Dependence of reaction velocity upon surface and agitation. Industrial & Engineering Chemistry 23:923–931.
  7. Zhang Y, Huo M, Zhou J, et al. (2010). DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. The AAPS Journal 12(3):263–271.

Last updated 2026-11-17.